Teladoc Health TDOC Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Teladoc Health in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Teladoc Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Teladoc Health's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Teladoc Health's accounts receivable, credit loss expense (reversal)?
- Teladoc Health (TDOC) reported accounts receivable, credit loss expense (reversal) of -$79K in Q1 2026.
- How has Teladoc Health's accounts receivable, credit loss expense (reversal) changed year-over-year?
- Teladoc Health's accounts receivable, credit loss expense (reversal) decreased by 233.9% year-over-year, from $59K to -$79K.
- What is the long-term trend for Teladoc Health's accounts receivable, credit loss expense (reversal)?
- Over 2 years (2021 to 2025), Teladoc Health's accounts receivable, credit loss expense (reversal) has grown at a -99.1% compound annual growth rate (CAGR), from $11.35M to $1K.